Payment overview · 2025
General Payments
$137.04
5 reported records · 3 companies
Healthcare provider profile · identity verified
Ashmead Ali, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CALIFORNIA CITY, CA · NPI 1215009113
Verified facts
What the public records show
CMS Open Payments records show Ashmead Ali, MD received $137.04 in general payments during 2025 across 5 reported records.
Novo Nordisk Inc accounted for 70.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 85 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $96.81 | 70.6% | 3 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $21.40 | 15.6% | 1 | 2025 |
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $18.83 | 13.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $96.81 | 3 |
| Food and Beverage | $40.23 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $64.54 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $32.27 | 1 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $21.40 | 1 | 2025 |
Source payment records
|
|||||
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $18.83 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 85 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
85 | 13 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 615 | 112 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 601 | 98 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 441 | 60 |
| Amlodipine Besylate | Amlodipine Besylate | 416 | 83 |
| Omeprazole | Omeprazole | 338 | 70 |
| Losartan Potassium | Losartan Potassium | 299 | 62 |
| Ibuprofen | Ibuprofen | 272 | 51 |
| Metformin Hcl | Metformin Hcl | 262 | 56 |
| Gabapentin | Gabapentin | 261 | 58 |
| Lisinopril | Lisinopril | 257 | 49 |
| Hydrochlorothiazide | Hydrochlorothiazide | 233 | 55 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 224 | 51 |
| Tamsulosin Hcl | Tamsulosin Hcl | 221 | 43 |
| Diclofenac Sodium | Diclofenac Sodium | 206 | 40 |
| Alendronate Sodium | Alendronate Sodium | 192 | 38 |
| Baclofen | Baclofen | 177 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 176 | 35 |
| Ketoconazole | Ketoconazole | 150 | 23 |
| Levothyroxine Sodium | Levothyroxine Sodium | 145 | 30 |
| Furosemide | Furosemide | 143 | 33 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 139 | 23 |
| Lorazepam | Lorazepam | 131 | 21 |
| Metoprolol Succinate | Metoprolol Succinate | 130 | 30 |
| Ondansetron Odt | Ondansetron | 129 | 29 |
| Azelastine Hcl | Azelastine Hcl | 127 | 16 |
| Atenolol | Atenolol | 126 | 25 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 119 | 19 |
| Pantoprazole Sodium | Pantoprazole Sodium | 119 | 26 |
| Ventolin Hfa | Albuterol Sulfate | 117 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 115 | 21 |
| Cephalexin | Cephalexin | 108 | 58 |
| Meclizine Hcl | Meclizine Hcl | 106 | 15 |
| Prednisone | Prednisone | 105 | 37 |
| Potassium Chloride | Potassium Chloride | 103 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 102 | 22 |
| Famotidine | Famotidine | 101 | 16 |
| Azithromycin | Azithromycin | 100 | 65 |
| Tramadol Hcl | Tramadol Hcl | 98 | 12 |
| Amoxicillin | Amoxicillin | 89 | 45 |
| Glipizide | Glipizide | 89 | 23 |
| Januvia | Sitagliptin Phosphate | 87 | 12 |
| Clonidine Hcl | Clonidine Hcl | 86 | 16 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 85 | 19 |
| Mometasone Furoate | Mometasone Furoate | 85 | 13 |
| Ozempic | Semaglutide | 85 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 84 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 83 | 19 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 81 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 78 | 14 |
| Dexlansoprazole Dr | Dexlansoprazole | 76 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 76 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 76 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 72 | 15 |
| Levetiracetam | Levetiracetam | 69 | 13 |
| Eliquis | Apixaban | 67 | 11 |
| Nitroglycerin | Nitroglycerin | 65 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 63 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 61 | 13 |
| Naproxen | Naproxen | 61 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | 11 |
| Jardiance | Empagliflozin | 60 | 11 |
| Carvedilol | Carvedilol | 57 | 13 |
| Lidocaine | Lidocaine | 57 | suppressed |
| Temazepam | Temazepam | 57 | 11 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 55 | suppressed |
| Ibu | Ibuprofen | 52 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 52 | suppressed |
| Spironolactone | Spironolactone | 52 | 11 |
| Hydrocortisone | Hydrocortisone | 51 | suppressed |
| Xarelto | Rivaroxaban | 48 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 46 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 46 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 45 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 45 | suppressed |
| Nifedipine Er | Nifedipine | 44 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 44 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | suppressed |
| Simvastatin | Simvastatin | 43 | suppressed |
| Alprazolam | Alprazolam | 42 | suppressed |
| Clonazepam | Clonazepam | 42 | suppressed |
| Sucralfate | Sucralfate | 41 | suppressed |
| Fluconazole | Fluconazole | 40 | 22 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 39 | suppressed |
| Valsartan | Valsartan | 38 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 37 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 36 | suppressed |
| Fluocinonide | Fluocinonide | 36 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 36 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 35 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | suppressed |
| Linzess | Linaclotide | 34 | suppressed |
| Mirtazapine | Mirtazapine | 34 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Latanoprost | Latanoprost | 32 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 32 | suppressed |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Myrbetriq | Mirabegron | 31 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Metronidazole | Metronidazole | 28 | 14 |
| Nystatin | Nystatin | 28 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 27 | suppressed |
| Movantik | Naloxegol Oxalate | 27 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 25 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Diazepam | Diazepam | 25 | suppressed |
| Ezetimibe | Ezetimibe | 25 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 24 | suppressed |
| Creon | Lipase/Protease/Amylase | 24 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 24 | 11 |
| Risperidone | Risperidone | 24 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 23 | suppressed |
| Gemfibrozil | Gemfibrozil | 22 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 22 | suppressed |
| Meloxicam | Meloxicam | 22 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Carbamazepine | Carbamazepine | 21 | suppressed |
| Chlorzoxazone | Chlorzoxazone | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 18 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 21 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 21 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Haloperidol | Haloperidol | 18 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Olanzapine | Olanzapine | 18 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Allopurinol | Allopurinol | 16 | suppressed |
| Brilinta | Ticagrelor | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Synthroid | Levothyroxine Sodium | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 14 | suppressed |
| Mesalamine | Mesalamine | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 14 | suppressed |
| Rybelsus | Semaglutide | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Nifedipine | Nifedipine | 13 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Xopenex Hfa | Levalbuterol Tartrate | 13 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Emtricitabine-Tenofovir Disop | Emtricitabine/Tenofovir (Tdf) | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Glimepiride | Glimepiride | 12 | suppressed |
| Hydrocortisone Butyrate | Hydrocortisone Butyrate | 12 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Nexium | Esomeprazole Magnesium | 12 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Norgestimate-Ethinyl Estradiol | Norgestimate-Ethinyl Estradiol | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $137.04 · 5 records | Novo Nordisk Inc | LifeVest, Ohtuvayre, Ozempic, Wegovy | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error